DDrare: Database of Drug Development for Rare Diseases

Ophthalmic emulsion (DrugBank: -)

2 diseases

ID	Disease name (Link within this page)	Number of trials
51	Scleroderma	1
53	Sjogren syndrome	1

51. Scleroderma [ 466 clinical trials, 536 drugs, (DrugBank: 142 drugs), 110 drug target genes, 210 drug target pathways]

Searched query = "Scleroderma", "Systemic sclerosis", "SSc", "dcSSc", "lcSSc"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 466 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00025818 (ClinicalTrials.gov)	May 2001	26/10/2001	Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome		Keratoconjunctivitis Sicca;Sjogren's Syndrome;Lupus Erythematosus, Systemic;Arthritis, Rheumatoid;Scleroderma, Systemic	Drug: Ophthalmic Emulsion	Allergan	NULL	Completed	18 Years	N/A	Both	290	Phase 3	United States

53. Sjogren syndrome [ 234 clinical trials, 270 drugs, (DrugBank: 85 drugs), 49 drug target genes, 174 drug target pathways]

Searched query = "Sjogren syndrome", "Sjögren syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 234 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00025818 (ClinicalTrials.gov)	May 2001	26/10/2001	Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome		Keratoconjunctivitis Sicca;Sjogren's Syndrome;Lupus Erythematosus, Systemic;Arthritis, Rheumatoid;Scleroderma, Systemic	Drug: Ophthalmic Emulsion	Allergan	NULL	Completed	18 Years	N/A	Both	290	Phase 3	United States